126 related articles for article (PubMed ID: 34110399)
1. All that glitters is not gold: pseudoplatelets associated with tumour lysis in high-blast-count AML.
Yuan Y; Boyle S
Blood; 2021 Jun; 137(23):3310. PubMed ID: 34110399
[No Abstract] [Full Text] [Related]
2. Pseudoplatelets in acute myeloid leukemia.
Chan RY; Vergara-Lluri M
Blood; 2015 Jul; 126(4):559. PubMed ID: 26421331
[No Abstract] [Full Text] [Related]
3. Acute Presentation of Tender Papules and Plaques in a Patient With Leukemia.
Saluja SS; Secrest AM; Florell SR
JAMA Dermatol; 2016 May; 152(5):571-2. PubMed ID: 26864885
[No Abstract] [Full Text] [Related]
4. [Pseudothrombocytes in acute leukemias].
Trpinac D; Veg M
Vojnosanit Pregl; 1993; 50(3):282-5. PubMed ID: 8212655
[TBL] [Abstract][Full Text] [Related]
5. Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis.
Graf M; Reif S; Kröll T; Hecht K; Nuessler V; Schmetzer H
Am J Hematol; 2006 Apr; 81(4):227-35. PubMed ID: 16550517
[TBL] [Abstract][Full Text] [Related]
6. Venetoclax-induced tumour lysis syndrome in acute myeloid leukaemia.
Esparza S; Muluneh B; Galeotti J; Matson M; Richardson DR; Montgomery ND; Coombs CC; Jamieson K; Foster MC; Zeidner JF
Br J Haematol; 2020 Jan; 188(1):173-177. PubMed ID: 31621058
[No Abstract] [Full Text] [Related]
7. Acute tumor lysis syndrome in a patient with chronic myelogenous leukemia in blast crisis: role of high-dose Ara-C.
Przepiorka D; Gonzales-Chambers R
Bone Marrow Transplant; 1990 Oct; 6(4):281-2. PubMed ID: 2085702
[TBL] [Abstract][Full Text] [Related]
8. Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia.
Corazza F; Hermans C; D'Hondt S; Ferster A; Kentos A; Benoît Y; Sariban E
Blood; 2006 Mar; 107(6):2525-30. PubMed ID: 16317100
[TBL] [Abstract][Full Text] [Related]
9. Selective blast cell reduction in elderly patients with acute myeloid leukemia secondary to myelodysplastic syndrome treated with methylprednisolone.
Suzuki K; Ohishi K; Sekine T; Masuya M; Katayama N
Int J Hematol; 2007 May; 85(4):344-9. PubMed ID: 17483080
[TBL] [Abstract][Full Text] [Related]
10. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis.
Lee EJ; Schiffer CA; Tomiyasu T; Testa JR
Leukemia; 1990 May; 4(5):350-3. PubMed ID: 2388480
[TBL] [Abstract][Full Text] [Related]
11. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
12. Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.
Razis E; Arlin ZA; Ahmed T; Feldman EJ; Puccio C; Cook P; Chun HG; Helson L; Mittelman A
Acta Haematol; 1994; 91(4):171-4. PubMed ID: 7976113
[TBL] [Abstract][Full Text] [Related]
13. Blast crisis.
Blood; 2009 Dec; 114(24):4917. PubMed ID: 20050125
[No Abstract] [Full Text] [Related]
14. [Differential diagnostic criteria of blast cells in the peripheral blood in acute myeloid leukemias].
Gaĭdukova SN; Guseva SA; Tishchenko LM
Vrach Delo; 1989 Sep; (9):38-41. PubMed ID: 2558447
[TBL] [Abstract][Full Text] [Related]
15. Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
Villgran V; Agha M; Raptis A; Hou JZ; Farah R; Lim SH; Redner RL; Im A; Sehgal A; Dorritie KA; Kiss JE; Normolle D; Boyiadzis M
Transfus Apher Sci; 2016 Oct; 55(2):216-220. PubMed ID: 27470709
[TBL] [Abstract][Full Text] [Related]
16. Platelet function in acute leukemias.
Naresh KN; Sivasankaran P; Veliath AJ
J Assoc Physicians India; 1993 Jun; 41(6):377-8. PubMed ID: 8005978
[TBL] [Abstract][Full Text] [Related]
17. Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels.
Sanchez-Correa B; Bergua JM; Campos C; Gayoso I; Arcos MJ; Bañas H; Morgado S; Casado JG; Solana R; Tarazona R
Cytokine; 2013 Mar; 61(3):885-91. PubMed ID: 23357299
[TBL] [Abstract][Full Text] [Related]
18. Intracellular ROS profile in hematopoietic progenitors of MDS patients: association with blast count and iron overload.
Chan LSA; Gu LC; Leitch HA; Wells RA
Hematology; 2021 Dec; 26(1):88-95. PubMed ID: 34000978
[No Abstract] [Full Text] [Related]
19. [Heterogeneity of leukemia cell phenotype. I. Variants of hetero- phenotype in relation to myeloid and erythrocytic markers of leukemic cells in acute leukemia and blast crisis of chronic myeloproliferative disorders].
Kemnitz J; Helmke M; Frend M; Bür T; Dominis M; Horitz H
Gematol Transfuziol; 1990 Aug; 35(8):9-14. PubMed ID: 2253865
[No Abstract] [Full Text] [Related]
20. Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts.
Le Dieu R; Taussig DC; Ramsay AG; Mitter R; Miraki-Moud F; Fatah R; Lee AM; Lister TA; Gribben JG
Blood; 2009 Oct; 114(18):3909-16. PubMed ID: 19710498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
